Focus on the "4 + 7" clinical allocation requirements of selected drugs issued by the health and health commission! Medical insurance bureau held a meeting to deploy the implementation of centralized purchase!

On January 25, the health and Health Commission issued the notice on doing a good job in the clinical allocation and use of selected drugs in the centralized purchase of drugs organized by the state, which put forward five requirements: first, attach great importance to the allocation and use of selected drugs, and the Party Central Committee and the State Council attach great importance to the health and well-being of the people The national organization of drug centralized purchase and use pilot is an important measure to implement the State Council's requirements of "ensuring the public to use high-quality and cheap drugs", which is a major reform of the previous drug centralized purchase system, as well as a concrete embodiment of the deepening development of China's medical reform The administrative departments of health and health in the pilot areas should firmly establish the "Four Consciousness", attach great importance to the clinical allocation and use of selected drugs, strengthen guidance and scheduling, and steadily promote the pilot Public medical institutions should implement the program requirements of the general office of the State Council, equip and reasonably use the selected drugs, ensure the dosage, and further reduce the burden of drug expenses on the masses 2、 The public health administrative departments at all levels shall strengthen the guidance and supervision of public medical institutions on the use of selected drugs, urge public medical institutions to purchase and use selected drugs in priority according to the agreed purchase volume, and ensure the completion of the contract amount within one year The administrative department of health and medical institutions shall not influence the reasonable use and supply guarantee of the selected drugs on the grounds of cost control, drug proportion and the requirements of drug varieties, specifications and quantities of medical institutions Public medical institutions should optimize the drug use structure, include the selected drugs in the drug prescription set and the basic drug supply catalogue of medical institutions, strictly implement the requirements of prescribing according to the common name of drugs, and ensure that the selected drugs are used preferentially under the same conditions 3、 In order to improve the rational use level of selected drugs, medical institutions should timely formulate and improve the clinical medication guidelines of selected drugs, and standardize the medication behaviors of doctors Vigorously carry out doctors' publicity and training to make them understand the policy significance of the national organization of drug centralized purchase and use pilot, master the basic principles and precautions of rational use of drugs, and improve the level of rational use Strictly implement the prescription management measures, regulations on the administration of pharmaceutical affairs in medical institutions, regulations on the administration of prescription reviews in hospitals (for Trial Implementation), relevant diagnosis and treatment specifications and medication guidelines, strengthen the prescription review and prescription reviews, and give full play to the role of clinical pharmacists to ensure the medication safety of patients For the situation that the use of selected drugs may lead to the adjustment of patients' drug use, each medical institution shall do a good job in clinical risk assessment, preparation of plans and material reserves, monitoring of drug use and emergency response, and explain to patients 4、 To establish and improve the relevant incentive mechanism and performance appraisal system, the administrative department of health and health should include the implementation of on-the-spot purchasing in public medical institutions in the performance appraisal of medical institutions, require medical institutions to include it in the performance appraisal of clinical departments and doctors, and establish incentive mechanism and preferential measures to encourage the use of selected drugs The proportion and ranking of selected drugs purchased and used by medical institutions shall be publicized regularly through the sunshine procurement platform, official website, etc to accept social supervision For the medical institutions, clinical departments and doctors who give priority to use and guarantee the dosage, they should be inclined in the reform of public hospitals, such as awarding and replenishing funds, appraising and appraising the excellent ones, and evaluating the professional titles; for those who can't be equipped in time according to the requirements or purchasing quantity is insufficient, which affects the patients' drug demand, they should make corresponding treatment in the evaluation of the medical institutions' grades and the assessment of the objective responsibility of the person in charge of the medical institutions, and for the medical treatment The organization shall take measures such as notification of criticism, rectification within a time limit, assessment and evaluation of unqualified products 5、 To monitor the clinical use of selected drugs, the provincial health administration should establish and improve the monitoring network of clinical use of drugs, and include all public medical institutions in the pilot cities in the monitoring scope We will make full use of information technology to monitor and analyze the purchase and use of selected drugs and their clinical effects, and master the progress of the work in the pilot areas Early warning shall be given to areas with potential problems, and on-site supervision shall be carried out when necessary to ensure the smooth implementation of the pilot work The circular also pointed out that the national health and Health Commission will timely organize supervision and inspection, and give national briefings and interviews to provinces and medical institutions with poor implementation On the same day, the national organization for drug centralized procurement and use pilot implementation work deployment meeting was held in Beijing The theme of this meeting is to thoroughly implement the spirit of the meeting of the Deep Reform Commission of the Central Committee and the executive meeting of the State Council, conscientiously implement the requirements of the notice of the general office of the State Council on printing and distributing the pilot program of centralized drug purchase and use organized by the state (GBF [2019] No 2, hereinafter referred to as No 2 document), and promote the relevant work of the pilot implementation Chen Jinfu, deputy director of the State Medical Insurance Bureau and director of the state organization drug centralized procurement and use pilot working group office, attended and delivered a speech Chen Jinfu stressed that the CPC Central Committee and the State Council attach great importance to the health and well-being of the people Since the 19th National Congress of the CPC, a set of "combination boxing" has been launched to solve the problem of "expensive medical treatment" and "expensive drug price" The pilot of centralized drug purchase and use organized by the state is an important part of the "combination boxing", which is not only a livelihood project to reduce the virtual high drug price and improve the sense of public access, but also a comprehensive deepening of the project The political task of reform is also to explore the mechanism of drug recruitment and purchase and the innovation of market-oriented price formation mechanism around the main problems and key links, which is of great significance Chen Jinfu asked that all regions should fully and accurately grasp the requirements of the pilot program, and in view of the long-term problems in drug bidding, such as "separation of bidding and procurement", "uncoupling of quantity and price" and "regardless of price", deeply analyze the nature of the problems, find out the crux of the system and mechanism, seize the reform window period and make a strong combination, and strive to achieve "four links and three links": Alliance procurement, quantity price linkage, bidding procurement Purchase use linkage, payment and interest mechanism linkage, system connectivity, policy connectivity and department connectivity, to achieve the "four promotion": to promote the return of drug prices to a reasonable level, to promote the healthy development of the pharmaceutical industry, to promote the improvement of clinical drug use level, to promote the income structure of medical institutions and the structure of medical insurance expenditure At present, the pilot project has entered the stage of result implementation and policy implementation Chen Jinfu stressed that all regions should improve their political positions, strengthen organizational leadership, establish the spirit of reform, and plan based on the overall situation The pilot office shall be responsible for the guidance and supervision of the whole process of the pilot, refine the division of labor of all departments, and promote the coordination and linkage of departments Joint procurement organizes and urges each pilot city to implement the procurement results at the operation level The pilot cities should complete the implementation work according to the unified arrangement, the standard and the table, set up the implementation plan scientifically, thoroughly implement the pilot policies, and focus on "four guarantees": ensuring the quality, supply, use and payment We should do a good job in public opinion guidance, strengthen risk prevention, formulate public opinion risk assessment and control programs, strengthen positive publicity and guidance, do a good job in the publicity, guidance and training of medical personnel, and ensure the smooth operation of the pilot work At the meeting, Zhong Dongbo, director of the price bidding Department of the state health insurance bureau, made a comprehensive interpretation of document 2 Jiao Yahui, deputy director of the medical administration bureau of the National Health Commission, made a specific deployment on the use of centralized procurement of selected drugs, requiring the health departments in the pilot areas to unblock the policy channel for priority use of selected drugs, urging public medical institutions to prioritize the purchase and use of selected drugs according to the agreed purchase volume, and ensuring the completion of the contract volume within one year Xu Shengmin, deputy inspector of the Department of drug supervision and administration of the State Food and drug administration, introduced the quality supervision of selected drugs, emphasizing the full implementation of the "four strictest" requirements of drug supervision, focusing on the supervision and inspection and product sampling, strengthening the supervision of drug production and circulation, so as to ensure the quality and safety of drugs from strict sampling and adverse reaction monitoring Leaders from 11 pilot cities including Beijing, Tianjin, Shanghai, Chongqing and relevant departments of the province attended the meeting.